LDL Size Distribution in Relation to Insulin Sensitivity and Lipoprotein Pattern in Young and Healthy Subjects

OBJECTIVE Smaller LDL particles are associated with an increased risk for coronary artery disease and have been found predominantly in subjects with the insulin resistance syndrome. Although insulin resistance has been suggested to be a basic defect, little is known about the relation between this predisposing factor (and associated metabolic disturbances) and LDL size distribution in young and metabolically healthy subjects. In the present study, we investigated the relation between insulin sensitivity, lipoprotein distribution, and LDL patterns in young adults to increase the understanding of the development of metabolic risk factors in an early phase of the life span. RESEARCH DESIGN AND METHODS Young, clinically healthy subjects (n = 50; age 21.1–30.6 years) were enrolled in the study. Glucose metabolism was characterized by peripheral insulin sensitivity assessed by a hyperinsulinemic-euglycemic clamp and by levels of fasting insulin, C-peptide, and glucose. Lipoproteins were measured, and LDL fractions were additionally characterized by the diameter of the major LDL peak, estimated by 2–16% polyacrylamide gradient gel electrophoresis. Cholesterol ester transfer was estimated with a fluorescent spectroscopic method that measures the transfer of fluorescent cholesteryl linoleate between exogenous donor and acceptor particles. In this assay system, cholesterylester transfer protein (CETP) activity was only influenced by the plasma CETP concentration therefore reflecting more likely the CETP mass. RESULTS In the entire study group, 47 subjects had LDL phenotype A (LDL diameter >25.75 nm) and 3 subjects had an intermediate phenotype (25.50–25.75 nm). An interrelation between LDL size and LDL triglyceride (LDL-TG) per apolipoprotein (apo) B (Spearman's rank correlation analysis; r = −0.78; P < 0.001) or LDL cholesterol ester (CE) per apoB (r = 0.58, P < 0.001) was found, and 39% of the plasma samples studied were characterized by a monodispersed LDL pattern. Furthermore, LDL diameters correlated negatively with total TGs (men: r = −0.52, P < 0.001; women: r = −0.61, P < 0.001) and positively with insulin sensitivity (total population: r = 0.54, P < 0.001). In addition, LDL size was inversely related to the [VLDL + LDL cholesterol (CH)]/HDL-CH ratio and positively to the HDL-CE/TG ratio, which were both related vice versa to CETP activity levels. A direct relation between CETP activity levels and LDL size or composition was not observed. In a linear regression analysis including parameters of lipoprotein metabolism (TG, HDL cholesterol, CETP activity level), glucose metabolism (insulin sensitivity, fasting insulin), and sex, only TGs predicted significantly for 62% of LDL size variability. If the total study population was evaluated according to quintiles of insulin sensitivity, increasing TGs (analysis of variance, Scheffe test; P < 0.05) and CETP activitiy levels (P < 0.05) were combined with decreasing LDL particle diameters (P < 0.05) and with a preponderance of a monodispersed LDL pattern (60%) in the most insulin-resistant group. CONCLUSIONS Among parameters of the lipoprotein and glucose metabolism, total TG is the single most important factor affecting LDL size variability, even in young adults. If the study population is evaluated according to insulin sensitivity, lipoprotein pattern is altered in a more atherogenic manner in the most insulin-resistant subjects. In this group, increasing TG and CETP activity levels are associated with decreasing LDL particle diameters and preponderance of a monodispersed LDL pattern. Although increasing CETP levels are combined with this particular lipoprotein profile, a direct relation to LDL size and composition is not found.

[1]  K. Greenlund,et al.  Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study. , 1997, Annals of epidemiology.

[2]  F. Tató,et al.  1.P.393 Fluorescent determination of CETP activity in plasma , 1997 .

[3]  P. Bianchi,et al.  Comparative clinical evaluation of the effect on carbohydrate and lipid metabolism of two norethisterone-containing hormonal contraceptives: Mesigyna and TriNovum. , 1997, Contraception.

[4]  F. Tató,et al.  Fluorescent determination of CETP activity in plasma , 1997 .

[5]  K. Saku,et al.  Fractional esterification rate of cholesterol in high density lipoprotein is correlated with low density lipoprotein particle size in children. , 1997, Journal of lipid research.

[6]  G. Franceschini,et al.  Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[7]  M. Taskinen,et al.  LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes. , 1995, Atherosclerosis.

[8]  A. Tall Plasma lipid transfer proteins. , 1995, Annual Review of Biochemistry.

[9]  B. Howard,et al.  Greater Effect of Diabetes on LDL size in Women Than in Men , 1994, Diabetes Care.

[10]  A. van Tol,et al.  Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[11]  J. Bagdade,et al.  Contribution of glycaemic control, endogenous lipoproteins and cholesteryl ester transfer protein to accelerated cholesteryl ester transfer in IDDM , 1994, European journal of clinical investigation.

[12]  P. Gambert,et al.  Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[13]  R. Bergman,et al.  Is there a sex difference in the association of plasma insulin level and insulin sensitivity with serum lipids and lipoproteins? , 1994, Metabolism: clinical and experimental.

[14]  C. Packard,et al.  Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. , 1994, Atherosclerosis.

[15]  A P Holmes,et al.  Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[16]  A Tremblay,et al.  Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. , 1993, The American journal of clinical nutrition.

[17]  R. Krauss,et al.  Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. , 1993, The Journal of clinical investigation.

[18]  P. Gambert,et al.  Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[19]  R. Krauss,et al.  Production of polyacrylamide gradient gels for the electrophoretic resolution of lipoproteins. , 1992, Journal of lipid research.

[20]  R. Krauss,et al.  LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[21]  Y. Marcel,et al.  Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. , 1992, Journal of lipid research.

[22]  R. Krauss,et al.  Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Mann,et al.  Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. , 1991, The Journal of clinical investigation.

[24]  A. Tall,et al.  Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[25]  P. Subbaiah,et al.  Accelerated cholesteryl ester transfer in patients with insulin‐dependent diabetes mellitus , 1991, European journal of clinical investigation.

[26]  R. Mensink,et al.  Diet-induced alteration in the activity of plasma lipid transfer protein in normolipidemic human subjects. , 1991, Atherosclerosis.

[27]  R. Krauss,et al.  Linkage analysis of low‐density lipoprotein subclass phenotypes and the apolipoprotein B gene , 1991, Genetic epidemiology.

[28]  H. Barakat,et al.  Influence of Obesity, Impaired Glucose Tolerance, and NIDDM on LDL Structure and Composition: Possible Link Between Hyperinsulinemia and Atherosclerosis , 1990, Diabetes.

[29]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[30]  R. Krauss,et al.  Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis. , 1990, Journal of lipid research.

[31]  H. Barakat,et al.  Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis. , 1990, Diabetes.

[32]  A N Peiris,et al.  Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. , 1989, Diabetes/metabolism reviews.

[33]  S. Grundy,et al.  Familial combined hyperlipidemia workshop , 1989 .

[34]  M. King,et al.  Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. , 1988, American journal of human genetics.

[35]  F. Karpe,et al.  Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. , 1988, Journal of lipid research.

[36]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[37]  A. Gotto,et al.  High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. , 1987, The Journal of clinical investigation.

[38]  R. Krauss,et al.  GENETIC CONTROL OF LOW-DENSITY-LIPOPROTEIN SUBCLASSES , 1986, The Lancet.

[39]  S. Srinivasan,et al.  Relationship of carbohydrate intolerance to serum lipoprotein profiles in childhood. The Bogalusa Heart Study. , 1985, Metabolism: clinical and experimental.

[40]  S. Srinivasan,et al.  Serum lipoproteins and endogenous sex hormones in early life: observations in children with different lipoprotein profiles. , 1985, Metabolism: clinical and experimental.

[41]  N. Nakaya,et al.  Increase in the density of lighter low density lipoprotein by hepatic triglyceride lipase. , 1985, Artery.

[42]  A. Tall,et al.  Lipoprotein lipase enhances the cholesteryl ester transfer protein-mediated transfer of cholesteryl esters from high density lipoproteins to very low density lipoproteins. , 1984, The Journal of biological chemistry.

[43]  S. Eisenberg,et al.  Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment. , 1984, The Journal of clinical investigation.

[44]  S. Eisenberg,et al.  Reversible modification of human plasma low density lipoproteins toward triglyceride-rich precursors. A mechanism for losing excess cholesterol esters. , 1982, The Journal of biological chemistry.

[45]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[46]  Y. Barenholz,et al.  In vitro production of human plasma low density lipoprotein-like particles. A model for very low density lipoprotein catabolism. , 1979, The Journal of biological chemistry.